It was confirmed that MSC can reduce lung injury and inflammation, and improve infiltration caused by pulmonary fibrosis. Recently, the acute respiratory distress syndrome (ARDS) has attracted much attention, especially due to pneumonia caused by the novel coronavirus (COVID-19 / SARS-CoV-2) that has spread throughout the world. At a critical moment like this, mesenchymal stem cell (MSC) treatment has become a new option to fight diseases.
Mesenchymal Stem Cell treatment for ARDS
